Posts for Ticker ‘ARST’

Top 10 Pre-Market Analyst Calls (AYR, ARST, GLS, HCBK, JRN, MAKO, PFCB, TLM, WAT, WW)

These are the top analyst upgrades and downgrades that 247WallSt.com is focusing on in pre-market trading this Wednesday morning:

  • Aircastle (NYSE: AYR) Downgraded to Neutral from Overweight at JPMorgan.
  • ArcSight (NASDAQ: ARST) started as Outperform at Wachovia; started as Equal Weight at Lehman Brothers.
  • Genesis Lease (NYSE: GLS) Downgraded to Neutral from overweight at JP Morgan.
  • Hudson City Banc (NASDAQ: HCBK) Downgraded to Market Perform from Outperform at FBR.
  • Journal Commun (NYSE: JRN) started as Outperform at Bear Stearns.
  • MAKO Surgical (NASDAQ: MAKO) Started as Market Perform at Wachovia; Started as Overweight at JPMorgan.
  • P.F. Chang’s (NASDAQ: PFCB) Downgraded to Underperform From Market Perform at FBR.
  • Talisman Energy (NYSE:TLM) raised to Buy from Hold at Citigroup.
  • Waters (NYSE: WAT) Raised To Overweight From Neutral at JPMorgan.
  • Watson Wyatt (NYSE: WW) raised to Buy from Hold at UBS.

Jon C. Ogg
March 26, 20008

IPO FILING: ArcSight, Inc., A Data Security Play (ARST)

ArcSight, Inc. has filed to come public via an IPO and has proposed the sale of up to $74.75 million for filing purposes.  The company will take the proposed ticker "ARST" on NASDAQ.  The filing lists Morgan Stanley and Lehman Brothers as lead underwriters, and lists Wachovia and RBC Capital Markets as co-managers.  ArcSight in short is a data security play.  More detailed data can be found on the compan’s website http://arcsight.com/.

Read More »